Welcome to Peptide Card of AntiTbPdb
This page displays user query in tabular form. |
RRRRRRRKDVY details |
Primary information | |
---|---|
ID | antitb_1610, |
Name | 24411680 |
N-Terminal modification | RY-11 |
C-Terminal Modification | RRRRRRRKDVY |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | None |
Chirality | Linear |
Nature | 10 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis RIF-susceptible |
Cell Line | MIC = 125 mg/L |
Inhibition Concentration | in vitro |
Sequence | 2014 |
Cytotoxicity | RAW 264.7 mouse macrophage |
In vivo Model | NA |
Lethal Dose | HC50= > 2000 mg/L on Human RBC |
Immune Responce | NA |
Mechanism of Action | NA |
Target | Stimulate TNF-α production |
Combination Therapy | Disrupt the mycobacterial membrane |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1614, |
Name | 24411680 |
N-Terminal modification | RY-11 |
C-Terminal Modification | RRRRRRRKDVY |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | None |
Chirality | Linear |
Nature | 10 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis RIF-Resistance |
Cell Line | MIC = 125 mg/L |
Inhibition Concentration | in vitro |
Sequence | 2014 |
Cytotoxicity | RAW 264.7 mouse macrophage |
In vivo Model | NA |
Lethal Dose | HC50= > 2000 mg/L on Human RBC |
Immune Responce | NA |
Mechanism of Action | NA |
Target | Stimulate TNF-α production |
Combination Therapy | Disrupt the mycobacterial membrane |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1615, |
Name | 24411680 |
N-Terminal modification | RY-11 |
C-Terminal Modification | RRRRRRRKDVY |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | None |
Chirality | Linear |
Nature | 10 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis RIF-Resistance |
Cell Line | MIC = 125 mg/L |
Inhibition Concentration | in vitro |
Sequence | 2014 |
Cytotoxicity | RAW 264.7 mouse macrophage |
In vivo Model | NA |
Lethal Dose | HC50= > 2000 mg/L on Human RBC |
Immune Responce | NA |
Mechanism of Action | NA |
Target | Stimulate TNF-α production |
Combination Therapy | Disrupt the mycobacterial membrane |
Other activities | NA |
PMID | RR-11 Peptide(31.25 mg/L) + Rifampicin (1.95mg/L) |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |